Shape-Sensing Robotic-Assisted Bronchoscopy in the Diagnosis of Pulmonary Parenchymal Lesions

CHEST Journal ◽  
2021 ◽  
Author(s):  
Or Kalchiem-Dekel ◽  
James G. Connolly ◽  
I-Hsin Lin ◽  
Bryan C. Husta ◽  
Prasad S. Adusumilli ◽  
...  
CHEST Journal ◽  
2021 ◽  
Vol 160 (4) ◽  
pp. A2531-A2533
Author(s):  
David Ost ◽  
Michael Pritchett ◽  
Janani Reisenauer ◽  
Michael Simoff ◽  
Javier Diaz-Mendoza ◽  
...  

Author(s):  
Janani Reisenauer ◽  
Michael J. Simoff ◽  
Michael A. Pritchett ◽  
David E. Ost ◽  
Adnan Majid ◽  
...  

CHEST Journal ◽  
2021 ◽  
Vol 160 (4) ◽  
pp. A1622-A1624
Author(s):  
Michael Pritchett ◽  
Leah Muller ◽  
David Ost ◽  
Janani Reisenauer ◽  
Adnan Majid ◽  
...  

2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Michael J. Simoff ◽  
Michael A. Pritchett ◽  
Janani S. Reisenauer ◽  
David E. Ost ◽  
Adnan Majid ◽  
...  

Abstract Background Traditional bronchoscopy provides limited approach to peripheral nodules. Shape-sensing robotic-assisted bronchoscopy (SSRAB, Ion™ Endoluminal System) is a new tool for minimally invasive peripheral nodule biopsy. We sought to answer the research question: Does SSRAB facilitate sampling of pulmonary nodules during bronchoscopists’ initial experience? Methods The lead-in stage of a multicenter, single-arm, prospective evaluation of the Ion Endoluminal System (PRECIsE) is described. Enrolled subjects ≥ 18 years old had recent computed tomography evidence of one or more solid or semi-solid pulmonary nodules ≥ 1.0 to ≤ 3.5 cm in greatest dimension and in any part of the lung. Subjects were followed at 10- and 30-days post-procedure. This stage provided investigators and staff their first human experience with the SSRAB system; safety and procedure outcomes were analyzed descriptively. Neither diagnostic yield nor sensitivity for malignancy were assessed in this stage. Categorical variables are summarized by percentage; continuous variables are summarized by median/interquartile range (IQR). Results Sixty subjects were enrolled across 6 hospitals; 67 nodules were targeted for biopsy. Median axial, coronal and sagittal diameters were < 18 mm with a largest cardinal diameter of 20.0 mm. Most nodules were extraluminal and distance from the outer edge of the nodule to the pleura or nearest fissure was 4.0 mm (IQR: 0.0, 15.0). Median bronchial generation count to the target location was 7.0 (IQR: 6.0, 8.0). Procedure duration (catheter-in to catheter-out) was 66.5 min (IQR: 50.0, 85.5). Distance from the catheter tip to the closest edge of the virtual nodule was 7.0 mm (IQR: 2.0, 12.0). Biopsy completion was 97.0%. No pneumothorax or airway bleeding of any grade was reported. Conclusions Bronchoscopists leveraged the Ion SSRAB’s functionality to drive the catheter safely in close proximity of the virtual target and to obtain biopsies. This initial, multicenter experience is encouraging, suggesting that SSRAB may play a role in the management of pulmonary nodules. Clinical Trial Registration identifier and date NCT03893539; 28/03/2019.


2007 ◽  
Vol 177 (4S) ◽  
pp. 347-347
Author(s):  
Carlo C. Passerotti ◽  
Hiep T. Nguyen ◽  
Carlos R. Estrada ◽  
Richard S. Lee ◽  
Craig A. Peters

2006 ◽  
Vol 175 (4S) ◽  
pp. 348-348
Author(s):  
Edward M. Gong ◽  
Albert A. Mikhail ◽  
Alvaro Lucioni ◽  
Marcelo A. Orvieto ◽  
Arieh L. Shalhav ◽  
...  

2005 ◽  
Vol 173 (4S) ◽  
pp. 228-228
Author(s):  
David I. Lee ◽  
Justin T. Lee ◽  
David Shepherd ◽  
Harrison M. Abrahams

Sign in / Sign up

Export Citation Format

Share Document